Annual Cash & Cash Equivalents
$219.87M$34.79M+18.79%
Summary
- Current Value
- As of today, RNA annual cash & cash equivalents is $219.87M, up +18.79% on
- Historical Performance
- RNA annual cash & cash equivalents is down -31.39% over the past 3 years, and up +132.47% over the past 5 years
- All-Time High Comparison
- RNA annual cash & cash equivalents is currently -35.41% below its historical high of $340.40M set on
- 3-Year Low Comparison
- RNA annual cash & cash equivalents is +18.79% above its 3-year low of $185.08M reached on
- Sector Comparison
- RNA annual cash & cash equivalents is higher than 79.17% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $219.87M | +18.8% | -31.4% | +132.5% | +7015.5% | |
| Quarterly Cash & Cash Equivalents | $1.88B | +18.1% | +362.5% | +449.9% | – | |
| Price | $72.37 | +135.0% | +264.9% | +185.8% | – | |
| Annual Current Assets | $1.54B | +152.3% | +275.1% | +1512.0% | +10000.0% | |
| Annual Total Liabilities | $138.94M | +8.7% | +201.1% | -14.4% | +208.0% | |
| Annual Working Capital | $1.44B | +172.2% | +278.6% | +1590.4% | +10000.0% | |
| Annual Net Income | -$322.30M | -51.9% | -173.1% | -1203.1% | -2773.6% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $340.40M | N/A | -35.4% |
| 5Y | $340.40M | -35.4% | |
| All | $340.40M | -35.4% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $185.08M | +18.8% | |
| 5Y | $185.08M | +18.8% | |
| All | $3.09M | +7015.5% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $219.87M | +18.8% | |
| $185.08M | -45.6% | |
| $340.40M | +6.2% | |
| $320.45M | -0.3% |
| Year | Value | Change |
|---|---|---|
| $321.46M | +239.9% | |
| $94.58M | +2,960.8% | |
| $3.09M | - |
FAQ
What is the current annual cash & cash equivalents of RNA?
As of today, RNA annual cash & cash equivalents is $219.87M
What is 1-year change in RNA annual cash & cash equivalents?
RNA annual cash & cash equivalents is up +18.79% year-over-year
What is 3-year change in RNA annual cash & cash equivalents?
RNA annual cash & cash equivalents is down -31.39% over the past 3 years
How far is RNA annual cash & cash equivalents from its all-time high?
RNA annual cash & cash equivalents is currently -35.41% below its historical high of $340.40M set on December 31, 2022
How does RNA annual cash & cash equivalents rank versus sector peers?
RNA annual cash & cash equivalents is higher than 79.17% of companies in Healthcare sector
When is RNA next annual earnings release?
The next annual earnings release for RNA is on
Quarterly Cash & Cash Equivalents
$1.88B$692.69M+58.55%
Summary
- Current Value
- As of today, RNA quarterly cash & cash equivalents is $1.88B, up +58.55% on
- Historical Performance
- RNA quarterly cash & cash equivalents is up +18.08% year-over-year, and up +362.54% over the past 3 years
- All-Time High Comparison
- RNA quarterly cash & cash equivalents is currently at its all-time high
- 3-Year Low Comparison
- RNA quarterly cash & cash equivalents is +245.72% above its 3-year low of $542.58M reached on
- Sector Comparison
- RNA quarterly cash & cash equivalents is higher than 95.31% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $1.88B | +58.5% | +18.1% | +362.5% | +449.9% | |
| Annual Cash & Cash Equivalents | $219.87M | – | +18.8% | -31.4% | +132.5% | |
| Price | $72.37 | +54.1% | +135.0% | +264.9% | +185.8% | |
| Quarterly Current Assets | $1.97B | +57.2% | +21.2% | +374.4% | +471.0% | |
| Quarterly Total Liabilities | $247.94M | +40.7% | +80.5% | +362.9% | +854.8% | |
| Quarterly Working Capital | $1.80B | +61.0% | +17.4% | +383.1% | +443.3% | |
| Quarterly Net Income | -$174.44M | -10.9% | -117.0% | -300.1% | -1425.0% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.88B | at high | |
| 3Y | $1.88B | at high | |
| 5Y | $1.88B | at high | |
| All | $1.88B | at high |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.18B | +58.5% | |
| 3Y | $542.58M | +245.7% | |
| 5Y | $279.46M | +571.2% | |
| All | $88.75M | +2013.6% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of RNA?
As of today, RNA quarterly cash & cash equivalents is $1.88B
What is RNA quarterly cash & cash equivalents most recent change?
RNA quarterly cash & cash equivalents was up +58.55% on September 30, 2025
What is 1-year change in RNA quarterly cash & cash equivalents?
RNA quarterly cash & cash equivalents is up +18.08% year-over-year
How far is RNA quarterly cash & cash equivalents from its all-time high?
RNA quarterly cash & cash equivalents is currently at its all-time high
How does RNA quarterly cash & cash equivalents rank versus sector peers?
RNA quarterly cash & cash equivalents is higher than 95.31% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- RNA Official Website www.aviditybiosciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990125000210/0001599901-25-000210-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990125000059/0001599901-25-000059-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna